Insider Selling: USANA Health Sciences, Inc. (NYSE:USNA) Director Sells $21,849.10 in Stock

USANA Health Sciences, Inc. (NYSE:USNA) Director Gilbert A. Fuller sold 490 shares of the firm’s stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $44.59, for a total value of $21,849.10. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

USANA Health Sciences Trading Up 0.3 %

USNA stock opened at $44.74 on Wednesday. The firm has a market cap of $858.91 million, a PE ratio of 13.94, a price-to-earnings-growth ratio of 1.38 and a beta of 0.94. The stock has a 50-day moving average price of $46.48 and a 200-day moving average price of $48.07. USANA Health Sciences, Inc. has a 1-year low of $41.45 and a 1-year high of $69.60.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings data on Tuesday, February 6th. The company reported $0.87 earnings per share for the quarter, beating the consensus estimate of $0.52 by $0.35. The company had revenue of $221.08 million during the quarter, compared to analyst estimates of $206.70 million. USANA Health Sciences had a net margin of 6.88% and a return on equity of 12.80%. On average, analysts forecast that USANA Health Sciences, Inc. will post 2.75 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in USNA. Quest Partners LLC bought a new stake in USANA Health Sciences during the fourth quarter worth $66,000. CWM LLC grew its stake in shares of USANA Health Sciences by 49.6% in the 4th quarter. CWM LLC now owns 1,267 shares of the company’s stock worth $68,000 after acquiring an additional 420 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of USANA Health Sciences by 60.6% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,376 shares of the company’s stock worth $198,000 after acquiring an additional 1,274 shares in the last quarter. Trexquant Investment LP bought a new position in shares of USANA Health Sciences during the fourth quarter valued at about $266,000. Finally, Teacher Retirement System of Texas bought a new position in shares of USANA Health Sciences during the third quarter valued at about $297,000. Institutional investors own 54.25% of the company’s stock.

Analyst Ratings Changes

USNA has been the subject of several analyst reports. StockNews.com upgraded shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research report on Friday, January 12th. DA Davidson lowered their price objective on shares of USANA Health Sciences from $48.00 to $46.00 and set a “neutral” rating for the company in a research report on Tuesday.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.